Literature DB >> 21895930

Focal laser interstitial thermotherapy (LITT) at 980 nm for prostate cancer: treatment feasibility in Dunning R3327-AT2 rat prostate tumour.

Pierre Colin1, Pierre Nevoux, Mohamad Marqa, Florent Auger, Xavier Leroy, Arnauld Villers, Philippe Puech, Serge Mordon, Nacim Betrouni.   

Abstract

OBJECTIVE: To examine the feasibility and reproducibility of laser interstitial thermotherapy (LITT) as a minimally invasive method for the treatment of prostate cancer.
MATERIALS AND METHODS: Heterotopic tumours of prostatic adenocarcinoma (Dunning R3327-AT2) were induced in 10 male Copenhagen rats. After preoperative magnetic resonance imaging (MRI), a 10-mm cylindrical diffusing fibre developed by our research department was inserted under ultrasonographic guidance into the tumour. LITT was performed with a 980-nm diode laser (power 5 W) for 75 s (fluence rate of 1145 J/cm(2)). Non-enhanced T2-weighted and dynamic gadolinium-enhanced T1-weighted MRI examinations were performed at baseline, 1 and 48 h after the procedure and correlated with histological findings.
RESULTS: The necrosis lesions induced by LITT were visible on MRI. The mean (SD) ellipsoid necrosis volumes were 0.748 (0.075) mL at 1 h and 0.982 (0.052) mL at 48 h after the LITT procedure, and significantly different (P < 0.001). Histological analysis showed a strong correlation (r = 0.87) with the mean necrosis volume obtained by MRI at 48 h after LITT.
CONCLUSIONS: In a prostatic adenocarcinoma model, 980-nm LITT induces reproducible necrosis volumes. Further characterization of the response to LITT in an animal model and in human tissues will be important in establishing the efficacy of the procedure for prostate cancer focal therapy.
© 2011 THE AUTHORS. BJU INTERNATIONAL © 2011 BJU INTERNATIONAL.

Entities:  

Mesh:

Year:  2011        PMID: 21895930     DOI: 10.1111/j.1464-410X.2011.10406.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  6 in total

1.  Photothermal cancer therapy by gold-ferrite nanocomposite and near-infrared laser in animal model.

Authors:  M Heidari; N Sattarahmady; N Azarpira; H Heli; A R Mehdizadeh; T Zare
Journal:  Lasers Med Sci       Date:  2015-12-22       Impact factor: 3.161

Review 2.  The prostate cancer focal therapy.

Authors:  Filippo Pesapane; Francesca Patella; Enrico Maria Fumarola; Edoardo Zanchetta; Chiara Floridi; Gianpaolo Carrafiello; Chloë Standaert
Journal:  Gland Surg       Date:  2018-04

Review 3.  Laser ablation as focal therapy for prostate cancer.

Authors:  Hannah Wenger; Ambereen Yousuf; Aytekin Oto; Scott Eggener
Journal:  Curr Opin Urol       Date:  2014-05       Impact factor: 2.309

4.  Focal laser ablation of prostate cancer: definition, needs, and future.

Authors:  Pierre Colin; Serge Mordon; Pierre Nevoux; Mohammed Feras Marqa; Adil Ouzzane; Philippe Puech; Gregory Bozzini; Bertrand Leroux; Arnauld Villers; Nacim Betrouni
Journal:  Adv Urol       Date:  2012-05-16

5.  Focal laser ablation of prostate cancer: numerical simulation of temperature and damage distribution.

Authors:  Mohamad-Feras Marqa; Pierre Colin; Pierre Nevoux; Serge R Mordon; Nacim Betrouni
Journal:  Biomed Eng Online       Date:  2011-06-02       Impact factor: 2.819

Review 6.  MRI-guided biopsies and minimally invasive therapy for prostate cancer.

Authors:  Sangeet Ghai; John Trachtenberg
Journal:  Indian J Urol       Date:  2015 Jul-Sep
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.